Singaporean Startup Meatiply Secures $3.75M for Cultured Meat and Functional Additives

Singapore-based startup Meatiply raises $3.75 million in a seed round co-led by AgFunder and Wavemaker Partners, with funding from SEEDS Capital. The additional funds will enhance R&D capacity, scale up manufacturing, and support co-development partnerships for cultured meat. Meatiply's scientifically proven method uses a blend of cell types to produce naturally occurring substances, targeting the functional foods industry. The startup plans to debut commercially in 2026 after the second closing of the seed round.

Founded in 2021, Meatiply focuses on a business-to-business (B2B) model through co-development partnerships, collaborating with existing food manufacturers to leverage their distribution and marketing skills. The startup aims to create complex, value-added compounds using cells for both plant-based and traditional food production. Investors, including AgFunder and SEEDS Capital, see Meatiply's vision to pioneer sophisticated and useful products with significant downstream cost reductions.

Meatiply's creative product strategy involves structured and unstructured products, offering potential benefits in wellness and nutraceutical sectors. The startup aims to produce novel cultured goods with different types of cultivated products. With a strategic focus on increasing cell differentiation and proliferation efficiency, Meatiply has already developed impressive prototypes, including chicken items and a smoked duck breast, drawing at least 50% of cells from animals.

Meatiply's target market includes Singapore, followed by China, South Korea, Japan, and the rest of East Asia. The startup acknowledges consumer preferences for healthier and more nourishing alternatives to traditional meat products. By avoiding scale issues and collaborating with enabling technology companies, Meatiply aims to establish itself as a key player in the cultured meat and functional additives industry.